Jump to main content.


Propionaldehyde Quickview (CASRN 123-38-6)

Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of toxicity data by U.S. EPA health scientists from several Program Offices, Regional Offices, and the Office of Research and Development.

Disclaimer: This QuickView represents a snapshot of key information. We suggest that you read the IRIS Summary to put this information into complete context.

For definitions of terms in the IRIS Web site, refer to the IRIS Glossary.

Status of Data for Propionaldehyde

File First On-Line: 09/30/2008; Last Significant Revision: 09/30/2008

Category (section)
Status
Last Revised
Oral RfD Assessment Discussion 09/30/2008
Inhalation RfC Assessment On-line 09/30/2008
Carcinogenicity Assessment Discussion 09/30/2008
Synonyms
  • Propanal
  • Propionic Aldehyde
  • Methylacetaldehyde
  • Propyl Aldehyde
  • Propaldehyde
  • Propylic Aldehyde
  • Propionaldehyde
  • 123-38-6
Propionaldehyde Source Documents
Revision History
Date Section Description
09/30/2008 I., II. RfD, RfC, and cancer assessment first on line.
Chronic Health Hazard Assessments for Noncarcinogenic Effects

Reference Dose for Chronic Oral Exposure (RfD)

Information reviewed but value not estimated. See IRIS Summary.

Top of page


Reference Concentration for Chronic Inhalation Exposure (RfC)

Critical Effect
Point of Departure*
UF MF RfC
Atrophy of olfactory epithelium BMCL10 (HEC): 8 mg/m3 1000 1 8x10-3 mg/m3

* The Point of Departure listed serves as a basis from which the Inhalation RfC was derived. See Discussion of Conversion Factors and Assumptions for more details.

Top of page

Carcinogenicity Assessment for Lifetime Exposure
  • Weight-of-Evidence Characterization
    • Inadequate information to assess carcinogenic potential
  • Weight-of-Evidence Narrative:
    • In accordance with the Guidelines for Carcinogen Risk Assessment (U.S. EPA, 2005a), there is "inadequate information to assess the carcinogenic potential" for propionaldehyde.
    • This may be a synopsis of the full weight-of-evidence narrative. See IRIS Summary.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure

  • Not Assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure

  • Not Assessed under the IRIS Program.

Top of page


Recent Additions | Advanced Search | IRIS Home | NCEA Home | ORD Home


Local Navigation


Jump to main content.